PROF. Mark Vigoda
PROFESSOR, HEAD OF THE RADIOTHERAPY UNIT AT THE HADASSAH UNIVERSITY HOSPITAL
Specialization
Radiation therapy:
- application of innovative linear accelerators Ethos and Novalis Turebeam STx 2016;
- Peptide Receptor Radionuclide Therapy (PRRT) based on radioactive Lutetium-177 isotopes for the treatment of gastrointestinal tumors and metastatic prostate cancer;
- brain tumor radiotherapy in children and adults/
Experience 37 years
Education
- 1985 — Graduated from the Faculty of Medicine at the Louis Pasteur University (Strasbourg, France)
- 1990 — Special course on malignant tumor pathogenesis and growth factors in the Royal London Hospital (UK)
Career history
- 1986–1991 — Specialization in oncology at the Hadassah University Hospital (Jerusalem, Israel)
- 1995–1997 — clinical practice and research at the Department of Radiation Oncology at the University of Michigan Medical Center (Ann Arbor, USA)
- 1997–1999 — Senior expert at the Department of Oncology at the Hadassah University Hospital
- Since 1999 — Head of the Radiotherapy Unit at the Hadassah University Hospital
Additional positions
Since 2007 — Chairperson of the Israeli Radiotherapy Forum
Prizes and awards
2018–2020 — included in the “Best Doctors in Israel” ranking published annually by FORBES magazine
Participation in associations:
- Israeli Association of Oncology
- American Association of Oncology
Language proficiency
English, French, Hebrew
